首页> 外文期刊>Behavioural Brain Research: An International Journal >Central relaxin-3 receptor (RXFP3) activation reduces elevated, but not basal, anxiety-like behaviour in C57BL/6J mice
【24h】

Central relaxin-3 receptor (RXFP3) activation reduces elevated, but not basal, anxiety-like behaviour in C57BL/6J mice

机译:中央松弛素-3受体(RXFP3)活化可减少C57BL / 6J小鼠中的升高,但不是基础,焦虑的行为

获取原文
获取原文并翻译 | 示例
       

摘要

Anxiety disorders are among the most prevalent neuropsychiatric conditions, but their precise aetiology and underlying pathophysiological processes remain poorly understood. In light of putative anatomical and functional interactions of the relaxin-3/RXFP3 system with anxiety-related neural circuits, we assessed the ability of central administration of the RXFP3 agonist, RXFP3-A2, to alter anxiety-like behaviours in adult C57BL/6J mice. We assessed how RXFP3-A2 altered performance in tests measuring rodent anxiety-like behaviour (large open field (LOF), elevated plus maze (EPM), light/dark (L/D) box, social interaction). We examined effects of RXFP3-A2 on low 'basal' anxiety, and on elevated anxiety induced by the anxiogenic benzodiazepine, FG-7142; and explored endogenous relaxin-3/RXFP3 signalling modulation by testing effects of an RXFP3 antagonist, R3(B1-22)R, on these behaviours. Intracerebroventricular (icv) injection of RXFP3-A2 (1 nmol, 15 min pre-test) did not alter anxiety-like behaviour under 'basal' conditions in the LOF, EPM or L/D box, but reduced elevated indices of FG-7142-induced (30 mg/kg, ip) anxiety-like behaviour in the L/D box and a single-chamber social interaction test. Furthermore, R3(B1-22)R (4 nmol, icy, 15 min pre-test) increased anxiety-like behaviour in the EPM (reflected by reduced entries into the open arms), but not consistently in the LOF, L/D box or social interaction tests, suggesting endogenous signaling only weakly participates in regulating 'basal' anxiety-like behaviour, in line with previous studies of relaxin-3 and RXFP3 gene knockout mice. Overall, these data suggest exogenous RXFP3 agonists can reduce elevated (FG-7142-induced) levels of anxiety in mice; data important for gauging how conserved such effects are, with a view to modelling human pathophysiology and the likely therapeutic potential of RXFP3-targeted drugs. (C) 2015 Elsevier B.V. All rights reserved.
机译:焦虑症是最普遍的神经精神状况之一,但它们精确的缓解学和潜在的病理生理过程仍然明白很差。鉴于焦虑相关神经电路的松弛素-3 / RxFP3系统的推定解剖和功能相互作用,我们评估了RXFP3激动剂RXFP3-A2的中央施用能力,以改变成人C57BL / 6J的焦虑的行为老鼠。我们评估了RXFP3-A2如何在测量啮齿动物焦虑的行为(大开场(LOF),升高的加迷宫(EPM),光/暗(L / D)盒,社交互动)中进行改变的性能。我们检查了RXFP3-A2对低“基础”焦虑的影响,以及焦虑苯并二氮杂卓,FG-7142诱导的升高;并通过RXFP3拮抗剂,R3(B1-22)R,对这些行为的效果来测试内源性放松-3 / RXFP3信号调制。 Introcentricular(ICV)注射RXFP3-A2(1nmol,15分钟的预测试)在LOF,EPM或L / D盒中的“基础”条件下没有改变焦虑的行为,但是FG-7142的索引升高 - 在L / D盒中诱导(30mg / kg,IP)焦虑的行为和单室社交互动测试。此外,R3(B1-22)R(4nmol,冰冷,15分钟预测试)增加了EPM中的焦虑状行为(通过降低的条目反射到张开臂中),但在LOF,L / D中不一致盒子或社交互动试验,建议内源性信号只能缺乏参与调节“基础”焦虑的行为,符合先前的弛豫素-3和RXFP3基因敲除小鼠的研究。总的来说,这些数据表明外源性RxFP3激动剂可以减少升高(FG-7142诱导的)小鼠焦虑水平;数据对于测量的数据是如何保守的这些效果,以旨在建模人类病理生理学和rxfp3靶向药物的可能治疗潜力。 (c)2015 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号